Sign in

CIK 0001385818

  • Non-accelerated filer
  • Smaller reporting company

AYTU BIOPHARMA, INC

Sign in to watch
Ticker
AYTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
470883144
Phone
+1 720-437-6580
Business address
7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
Former names
AYTU BIOSCIENCE, INC, Rosewind CORP
  1. 4 Returned to the company Director returned 40,000 shares (to the company)
  2. 4 Open-market buy Chief Executive Officer bought 112,371 shares at $0.22 ($25,047)
  3. 4 Open-market buy Chief Commercial Officer bought 100,000 shares at $0.24 ($24,480)
  4. 4/A Open-market buy Chief Financial Officer bought 90,000 shares at $0.23 ($20,700)
  5. 4/A Open-market buy Chief Executive Officer bought 222,000 shares at $0.24 ($52,614)
  6. 4 Grant or award Chief Executive Officer acquired 222,000 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 90,000 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Director acquired 6,500 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Other acquisition Director acquired 9,044 shares (other)
  16. 4 Grant or award Director acquired 187,804 shares (grant or award)
  17. 4 Grant or award Director acquired 187,804 shares (grant or award)
  18. 4 Grant or award Director acquired 187,804 shares (grant or award)
  19. 4 Grant or award Director acquired 187,804 shares (grant or award)
  20. 4 Grant or award Chief Executive Officer acquired 800,000 shares (grant or award)

Page 4 of 10 · 187 filings